Back
Atara Biotherapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
$6.91
Seasonality Move:
-15.4%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing selling pressure, which indicates risk of future bearish movement.
Atara Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.97 | Buy |
20-day SMA: | 7.31 | Sell |
50-day SMA: | 9.39 | Sell |
200-day SMA: | 9.77 | Sell |
8-day EMA: | 7.05 | Buy |
20-day EMA: | 7.44 | Sell |
50-day EMA: | 8.63 | Sell |
200-day EMA: | 12.13 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -49880 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.69 - 8.75) | Sell |
Bollinger Bands (100): | (7.56 - 12.88) | Sell |
Atara Biotherapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.17 while ATRA 8-day simple moving average is 6.97, which is a Buy signal.
-
The stock price of ATRA is 7.17 while Atara Biotherapeutics 20-day SMA is 7.31, which makes it a Sell.
-
Atara Biotherapeutics 50-day simple moving average is 9.39 while ATRA share price is 7.17, making it a Sell technically.
-
ATRA stock price is 7.17 and Atara Biotherapeutics 200-day simple moving average is 9.77, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a SellThe current Atara Biotherapeutics [ATRA] share price is $7.17. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
42M
Price in USD:
7.17
Share Volume:
49.9K
Atara Biotherapeutics 52-Week Range
52-Week High:
20.81
52-Week Low:
5.40
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 7.17 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 7.17 while ATRA 8-day exponential moving average is 7.05, which is a Buy signal.
-
The stock price of ATRA is 7.17 while Atara Biotherapeutics 20-day EMA is 7.44, which makes it a Sell.
-
Atara Biotherapeutics 50-day exponential moving average is 8.63 while ATRA share price is 7.17, making it a Sell technically.
-
ATRA stock price is 7.17 and Atara Biotherapeutics 200-day simple moving average is 12.13, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.60 per share, and an increase next year of $4.98 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting Atara Biotherapeutics is a Sell
-
Atara Biotherapeutics Relative Strength Index (RSI) is 45.16, which suggest Atara Biotherapeutics is oversold
-
The Bollinger Bands (25) for Atara Biotherapeutics is (6.69 - 8.75), which suggest Atara Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.56 - 12.88), which suggest Atara Biotherapeutics is a Sell
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.